Announced
Completed
Financials
Tags
Private
Domestic
Single Bidder
Majority
Acquisition
Friendly
United States
pharmaceutical company
Pharmaceuticals
Completed
Synopsis
Prime Therapeutics, a management services company, completed the acquisition of Magellan Rx, a pharmacy benefits manager, from Centene, a publicly traded managed care company, for $1.35bn. "This is a timely and important move. As pharmacy costs balloon, bold action is necessary. By bringing together the capabilities and talents of Prime and Magellan Rx, we are positioned to deliver breakthrough value to the clients and members we serve. We are excited about the solutions our shared teams will bring to the industry as we strive to deliver progress against the Quadruple Aim," Ken Paulus, Prime Therapeutics CEO and President.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.